Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8F2A | 8F2A | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 8F2A | P30988 | Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation) | |
| 7TZF | P63092 | Human Amylin3 Receptor in complex with Gs and rat amylin peptide | |
| 7TZF | P62873 | Human Amylin3 Receptor in complex with Gs and rat amylin peptide | |
| 7TZF | O60896 | Human Amylin3 Receptor in complex with Gs and rat amylin peptide | |
| 7TZF | P59768 | Human Amylin3 Receptor in complex with Gs and rat amylin peptide | |
| 7TZF | 7TZF | Human Amylin3 Receptor in complex with Gs and rat amylin peptide | |
| 7TZF | P12969 | Human Amylin3 Receptor in complex with Gs and rat amylin peptide | |
| 7TZF | P30988 | Human Amylin3 Receptor in complex with Gs and rat amylin peptide | |
| 4CA6 | P12821 | Human Angiotensin converting enzyme N-domain in complex with a phosphinic tripeptide FI | |
| 4CA5 | P12821 | Human Angiotensin converting enzyme in complex with a phosphinic tripeptide FI | |
| 2XY9 | P12821 | Human Angiotensin converting enzyme in complex with phosphinic tripeptide | |
| 8QFX | P12821 | Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide IPP | |
| 8QFX | 8QFX | Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide IPP | |
| 8QHL | P12821 | Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide VPP | |
| 8QHL | 8QHL | Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide VPP | |
| 2HYV | P07355 | Human Annexin A2 with heparin hexasaccharide bound | |
| 2HYU | P07355 | Human Annexin A2 with heparin tetrasaccharide bound | |
| 6OML | 6OML | Human BMP chimera BV261 | Bone morphogenetic protein 2 |
| 6OMO | P22004 | Human BMP6 homodimer | Bone morphogenetic protein 6 |
| 5LKR | P06276 | Human Butyrylcholinesterase complexed with N-Propargyliperidines | Cholinesterase (E.C.3.1.1.8) |
| 6F7Q | P06276 | Human Butyrylcholinesterase complexed with N-Propargyliperidines | |
| 6QAD | P06276 | Human Butyrylcholinesterase in complex with ((S)-2-(butylamino)-N-(2-(4-(dimethylamino)cyclohexyl)ethyl)-3-(1H-indol-3-yl)propanamide | |
| 7QHD | P06276 | Human Butyrylcholinesterase in complex with (S)-1-(4-((2-(1H-indol-3-yl)ethyl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide | |
| 7QHE | P06276 | Human Butyrylcholinesterase in complex with (S)-1-(4-((naphthalen-1-yl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide | |
| 6QAA | P06276 | Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(2-cycloheptylethyl)-3-(1H-indol-3-yl)propanamide | |
| 6QAC | P06276 | Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(3-cycloheptylpropyl)-3-(1H-indol-3-yl)propanamide | |
| 6QAB | P06276 | Human Butyrylcholinesterase in complex with (S)-N-(1-((2-cycloheptylethyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-N,N-dimethylbutan-1-aminium | |
| 6QAE | P06276 | Human Butyrylcholinesterase in complex with (S)-N2-butyl-N1-(2-cycloheptylethyl)-3-(1H-indol-3-yl)-N1,N2-dimethylpropane-1,2-diamine | |
| 6T9P | P06276 | Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1R)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide | |
| 6T9S | P06276 | Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide | |
| 7BO4 | P06276 | Human Butyrylcholinesterase in complex with 3-(2-(butyl(2-cycloheptylethyl)amino)ethyl)-1H-indol-6-ol | |
| 7BO3 | P06276 | Human Butyrylcholinesterase in complex with N-(2-(1H-Indol-3-yl)ethyl)-2-cycloheptyl-N-methylethan-1-amine | |
| 2QKI | P01024 | Human C3c in complex with the inhibitor compstatin | |
| 2QKI | 2QKI | Human C3c in complex with the inhibitor compstatin | |
| 6V7Z | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
| 6V7Z | 6V7Z | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
| 6V7Z | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
| 6V7Z | 6V7Z | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
| 6V7Z | P61769 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
| 6V7Y | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
| 6V7Y | 6V7Y | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
| 6V7Y | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
| 6V7Y | 6V7Y | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
| 6V7Y | P61769 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
| 8SOS | P15813 | Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 | |
| 8SOS | 8SOS | Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 | |
| 8SOS | P15813 | Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 | |
| 8SOS | 8SOS | Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 | |
| 8SOS | P61769 | Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 |
